Electronic Prescribing and Electronic Transmission of Discharge Medication Lists

NCT00603070 | Completed

• 1 other identifier: R18HS017029-01
• Study Type: observational
• Target: 130
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is twofold:

1. 1.to measure the effects of transitioning from one electronic prescribing system to another in the ambulatory setting on medication errors and human-computer interactions
2. 2.to evaluate the impact of electronic transmission of discharge medication lists to the ambulatory setting on medication discrepancies and adverse drug events

Conditions

Medication Errors

Keywords

Medication Errors; Adverse Drug Events; Patient Safety; Electronic Prescribing Systems; Medication Reconciliation

Outcome Measures

Primary Outcomes (3)

• Prescription medication errors

  2 weeks prior, 3 months, 1 year after intervention and 2 years after intervention

• Medication discrepancies (as detected on a comparison between inpatient and outpatient medical records)

  30 days after patient is discharged from hospital

• Patient adverse drug events (as determined by patient telephone interview and medical record review)

  30 days after patient hospital discharge

Secondary Outcomes (1)

• Human-Computer interactions as measured by physician interview and direct observation of physician work

  3 months after intervention

Study Arms (2)

1

All physicians and nurse practitioners at 1 ambulatory care clinics

Other: E-prescribing system

2

All physicians and nurse practitioners at 1 ambulatory care clinics

Other: Electronic transmission of medication discharge lists

Interventions

E-prescribing system OTHER

Transition from home-grown to vendor-based ambulatory e-prescribing systems

Also known as: WebCIS, CLIMACS, EpicCare, Eclypsis

1

Electronic transmission of medication discharge lists OTHER

Patient discharge medication lists will be transmitted upon discharge from their inpatient medical record to their outpatient medical record and their outpatient provider will be notified of this transmission.

2

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Physicians and Nurse Practitioners from 2 office practices in the Ambulatory Care Network at NYPH, Associates in Internal Medicine (AIM) on the Columbia campus and Cornell Internal Medicine Associates (CIMA) on the Cornell campus.

You may qualify if:

• Physicians or nurse practitioners with at least 4 clinic sessions per week

Sponsors & Collaborators

• Weill Medical College of Cornell University: lead
• Agency for Healthcare Research and Quality (AHRQ): collaborator
• New York Presbyterian Hospital: collaborator
• Columbia University: collaborator
• Oregon Health and Science University: collaborator

Study Sites (1)

Weill Cornell Internal Medicine Associates

New York, New York, 10021, United States

Location

Related Publications (3)

• Abramson EL, Malhotra S, Osorio SN, Edwards A, Cheriff A, Cole C, Kaushal R. A long-term follow-up evaluation of electronic health record prescribing safety. J Am Med Inform Assoc. 2013 Jun;20(e1):e52-8. doi: 10.1136/amiajnl-2012-001328. Epub 2013 Apr 11.

  PMID: 23578816 DERIVED

• Abramson EL, Patel V, Malhotra S, Pfoh ER, Nena Osorio S, Cheriff A, Cole CL, Bunce A, Ash J, Kaushal R. Physician experiences transitioning between an older versus newer electronic health record for electronic prescribing. Int J Med Inform. 2012 Aug;81(8):539-48. doi: 10.1016/j.ijmedinf.2012.02.010. Epub 2012 Mar 30.

  PMID: 22465355 DERIVED

• Abramson EL, Malhotra S, Fischer K, Edwards A, Pfoh ER, Osorio SN, Cheriff A, Kaushal R. Transitioning between electronic health records: effects on ambulatory prescribing safety. J Gen Intern Med. 2011 Aug;26(8):868-74. doi: 10.1007/s11606-011-1703-z. Epub 2011 Apr 16.

  PMID: 21499828 DERIVED

MeSH Terms

Conditions

Drug-Related Side Effects and Adverse Reactions

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders

Study Officials

• Rainu Kaushal, MD, MPH

  Weill Medical College of Cornell University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 15, 2008
• First Posted: January 28, 2008
• Study Start: March 1, 2008
• Primary Completion: March 1, 2011
• Study Completion: March 1, 2011
• Last Updated: February 20, 2012

Record last verified: 2012-02

Locations

US (1)